Media coverage about Bioamber (NYSE:BIOA) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Bioamber earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned media headlines about the biotechnology company an impact score of 46.1393160510484 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the news articles that may have impacted Accern Sentiment Analysis’s scoring:

Several analysts have recently commented on BIOA shares. Cowen restated a “hold” rating and set a $1.00 target price on shares of Bioamber in a report on Friday, November 10th. ValuEngine cut Bioamber from a “sell” rating to a “strong sell” rating in a report on Friday, December 1st. Finally, HC Wainwright restated a “buy” rating and set a $12.00 target price on shares of Bioamber in a report on Wednesday, November 8th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $6.50.

Bioamber (BIOA) remained flat at $$0.39 during trading on Friday. 654,514 shares of the company were exchanged, compared to its average volume of 995,031. The company has a current ratio of 1.08, a quick ratio of 0.75 and a debt-to-equity ratio of 0.24. Bioamber has a 1 year low of $0.32 and a 1 year high of $6.24.

TRADEMARK VIOLATION WARNING: This piece was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-bioamber-bioa-stock-price/1756276.html.

About Bioamber

BioAmber Inc (BioAmber), formerly DNP Green Technology, Inc, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products.

Insider Buying and Selling by Quarter for Bioamber (NYSE:BIOA)

Receive News & Ratings for Bioamber Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioamber Inc and related companies with MarketBeat.com's FREE daily email newsletter.